直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Chiron Corp. v. Eli Lilly and Vertex Pharmaceutical

Chiron Corp.

Eli Lilly and Vertex Pharmaceuticals 

Represented Eli Lilly against charges of infringement in the development of an HCV small molecule therapeutic, resulting in a favorable settlement.

Chiron Corp. v. Eli Lilly and Vertex Pharmaceuticals , 4:98-cv-02974, N.D. Cal., Judges Wilken, Hamilton

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Biologics

Related Experiences

Alzheimer's Institute of America, Inc. v. Eli Lilly and Company

Eli Lilly and Company

Insight Development Corp. v. Hewlett-Packard

Hewlett-Packard

With hundreds of millions of dollars at stake in revolutionary technology involving genetic engineering, Finnegan prevails for Eli Lilly

Eli Lilly

Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.; ICOS

Hospira, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.

Eli Lilly and Company v. Genentech, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Drexler Technology Corp. v. Sony Corp.

Sony Corp.

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP